PPT-Cardiovascular Outcomes Trials with Antihyperglycemic Agents

Author : liane-varnes | Published Date : 2019-03-05

CVOTs 1 FDA CVOT Guidance2008 Timeline of Major Diabetes Outcomes Trials 2 Blue Intensive vs standard control using same set of glucoselowering agents Purple Intensive

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Cardiovascular Outcomes Trials with Anti..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Cardiovascular Outcomes Trials with Antihyperglycemic Agents: Transcript


CVOTs 1 FDA CVOT Guidance2008 Timeline of Major Diabetes Outcomes Trials 2 Blue Intensive vs standard control using same set of glucoselowering agents Purple Intensive control with a specific agent vs standard care. Pharmacologic Management of Type 2 . Diabetes . Chapter 13. (Updated July 2015). William Harper, Maureen Clement, Ronald Goldenberg,. Amir Hanna, Andrea Main, . Ravi . Retnakaran. , . Diana . Sherifali,Vincent. Sampling from Extremes. Padmanabhan S et al. . PLoS. Genet 2011. Cardiovascular Continuum. Sampling from Extremes. Padmanabhan S et al. . PLoS. Genet 2011. Cardiovascular Continuum. UMOD. Gene. Padmanabhan S et al. . Christina McConnell, PGY-3. Which of the following is NOT one of the diagnostic criteria for lupus?. Biopsy proven lupus nephritis with a positive ANA. Hemolytic anemia. Psychosis. Single joint swelling. Toni . Mustahsani. . Aprami. , dr., . Sp.PD. , Sp.JP. Department of Cardiology and Vascular Medicine. Cardiovascular Subdivision, Department of Internal Medicine. Hasan. . Sadikin. Hospital/Medical School, . Slide 1: . Target. population/question. 2. 09/01/2018. Patients with inflammatory joint disorders, particularly rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. To update the EULAR 2009 cardiovascular disease (. The Heart. The Heart. The Heart. A fist-sized, cone-shaped muscle (the myocardium) that beats, on average, 80 times per minute . . Divided into right and left sides by a muscular wall, the septum . . Diseases of the Cardiovascular System. 20.3 Cardiovascular and Lymphatic System Diseases Caused by Microorganisms. A. Endocarditis . 1. Inflammation of the endocardium . 2. Usually refers to an infection of the valves of the heart. Page 1 of 20 UnitedHealthcare Commercial Medical Policy Effective 0 6 / 01 / 2022 Proprietary Information of UnitedHealthcare. Copyright 202 2 United HealthCare Services, Inc. UnitedHealthcareComme 1 Cardiovascular Disease in Virginia Cardiovascular disease is the most common cause of acute and chronic illness globally, in the U.S. and in Virginia. Affecting the heart and blood vessels, cardio Bread:. Dough contains . yeast. , which ferment sugars to . carbon dioxide. . Further expands on baking.. Scones:. Made with . baking powder . that reacts with water to form . carbon dioxide. Choux buns. A 2023 Presidential Advisory From the AHA. Definition of . Cardiovascular-Kidney-Metabolic Syndrome (CKM). A systemic disorder characterized by pathophysiologic interactions among metabolic risk factors, chronic kidney disease, and the cardiovascular system, leading to multi-organ dysfunction and a high rate of adverse cardiovascular outcomes.. An Introduction to the 2022 ACC Workforce Health Policy Statement. Special Thanks To:. Slide Set Authors. Natalie Stokes, MD and Pamela S. Douglas, MD. 2022 ACC Workforce Health Policy Statement on . Second Annual Retreat. December 11. th. , 2017 . Nadia . Giannetti. . MD. Chief. , Division of Cardiology . MUHC. Ariane Marelli . MD, . MPH. Director of Cardiovascular Research . MUHC. Background. In spring 2017, a grid developed to categorize tertiary and quaternary clinical activities across the McGill RUIS. A Scientific Statement From the AHA. Definition of . Cardiovascular-Kidney-Metabolic Syndrome (CKM). A systemic disorder characterized by pathophysiologic interactions among metabolic risk factors, chronic kidney disease, and the cardiovascular system, leading to multi-organ dysfunction and a high rate of adverse cardiovascular outcomes..

Download Document

Here is the link to download the presentation.
"Cardiovascular Outcomes Trials with Antihyperglycemic Agents"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents